Retrospective Genomic Characterization of a 2017 Dengue Virus Outbreak, Burkina Faso

Knowledge of contemporary genetic composition of dengue virus (DENV) in Africa is lacking. By using next-generation sequencing of samples from the 2017 DENV outbreak in Burkina Faso, we isolated 29 DENV genomes (5 serotype 1, 16 serotype 2 [DENV-2], and 8 serotype 3). Phylogenetic analysis demonstra...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases Vol. 28; no. 6; pp. 1198 - 1210
Main Authors: Letizia, Andrew G., Pratt, Catherine B., Wiley, Michael R., Fox, Anne T., Mosore, Mba, Agbodzi, Bright, Yeboah, Clara, Kumordjie, Selassie, Di Paola, Nicholas, Assana, Kone Cisse, Coulidiaty, David, Ouedraogo, Casimir, Bonney, Joseph H. Kofi, Ampofo, William, Tarnagda, Zékiba, Sangaré, Lassana
Format: Journal Article
Language:English
Published: United States U.S. National Center for Infectious Diseases 01.06.2022
Centers for Disease Control and Prevention
Subjects:
ISSN:1080-6040, 1080-6059, 1080-6059
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Knowledge of contemporary genetic composition of dengue virus (DENV) in Africa is lacking. By using next-generation sequencing of samples from the 2017 DENV outbreak in Burkina Faso, we isolated 29 DENV genomes (5 serotype 1, 16 serotype 2 [DENV-2], and 8 serotype 3). Phylogenetic analysis demonstrated the endemic nature of DENV-2 in Burkina Faso. We noted discordant diagnostic results, probably related to genetic divergence between these genomes and the Trioplex PCR. Forward and reverse1 primers had a single mismatch when mapped to the DENV-2 genomes, probably explaining the insensitivity of the molecular test. Although we observed considerable homogeneity between the Dengvaxia and TetraVax-DV-TV003 vaccine strains as well as B cell epitopes compared with these genomes, we noted unique divergence. Continual surveillance of dengue virus in Africa is needed to clarify the ongoing novel evolutionary dynamics of circulating virus populations and support the development of effective diagnostic, therapeutic, and preventive countermeasures.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1080-6040
1080-6059
1080-6059
DOI:10.3201/eid2806.212491